Message Font: Serif | Sans-Serif
No. of Recommendations: 0
Affymetrix and Incyte Genomics Settle All Patent Infringement Litigation

PALO ALTO, Calif. and SANTA CLARA, Calif., Dec 21, 2001 /PRNewswire via COMTEX/ -- Incyte Genomics, Inc. (INCY), the leading genomics information company and Affymetrix, Inc., (AFFX) the leader in creating breakthrough tools for the genomic revolution, today announced a comprehensive settlement of all existing infringement litigation between the two companies. The first lawsuit involved several of Affymetrix microarray-related patents (U.S. Patent Nos. 5,445,934, 5,744305, 5,800,992, 5,871,928, 6,040,193). The second lawsuit involved Incyte's RNA amplification patents (U.S. Patent Nos. 5,716,785, 5,891,636). The companies have agreed to cross-licenses under their respective intellectual property portfolios. Financial terms were not disclosed. Affymetrix and Incyte also are investigating possible future commercial agreements between the companies.

Print the post  


What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.